NICE rejects immunotherapy drug for breast cancer

Watchdog wants manufacturer to make drug more cost-effective Related items fromOnMedica New breast cancer drug ‘unaffordable’ for NHS NICE rejects breast cancer drug for NHS funding Pledge to give all women same level of cancer care HRT users told to discuss breast cancer risk with GP Benefit of Herceptin in more breast cancer cases
Source: OnMedica Latest News - Category: UK Health Source Type: news